Ozarelix
Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be used in the research of prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 295350-45-7
- Formula: C72H96ClN17O14
- Molecular Weight:1459.09
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Ozarelix (0-20 ng/mL, 72 h) inhibits PC3 and DU145 cell proliferation[1].
Ozarelix (0-20 ng/mL, 72 h) induces apoptosis in PC3 and DU145 cells[1].
Ozarelix (20 ng/mL, 72 h) triggers caspase 8-dependent caspase 3 activation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Serum-starved PC3 and DU145 cells
-
Concentration:0, 5, 10, 20 ng/mL
-
Incubation Time:0, 24, 48, 72, 96 h
-
Result:Inhibited cell proliferation in a dose and time-dependent manner.
-
Cell Line:PC3 and DU145 cells
-
Concentration:0, 5, 10, 20 ng/mL
-
Incubation Time:72 h
-
Result:Increased the levels of p21 and p27 both in PC3 and DU145 cells.
Decreased levels of anti-apoptotic proteins such as Bcl2 and Bcl-Xl.
Upregulated Erk and p38MAPK activity.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 295350-45-7
-
Molecular Weight 1459.09
-
Formula C72H96ClN17O14
-
Synonyms
D-63153
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)